Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 249.53B | 249.53B | 229.86B | 236.24B | 228.59B | 220.45B |
Gross Profit | 88.37B | 88.37B | 75.42B | 79.46B | 77.15B | 73.29B |
EBITDA | 19.14B | 19.14B | 15.66B | 16.41B | 15.64B | 14.73B |
Net Income | 8.13B | 8.13B | 6.36B | 7.24B | 7.01B | 7.05B |
Balance Sheet | ||||||
Total Assets | 228.17B | 228.17B | 194.95B | 194.33B | 189.91B | 187.91B |
Cash, Cash Equivalents and Short-Term Investments | 31.29B | 31.29B | 31.30B | 24.57B | 24.80B | 38.94B |
Total Debt | 37.82B | 37.82B | 9.32B | 12.19B | 10.76B | 12.66B |
Total Liabilities | 96.20B | 96.20B | 65.80B | 67.37B | 67.02B | 64.08B |
Stockholders Equity | 131.81B | 131.81B | 128.84B | 126.62B | 122.55B | 123.18B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -4.98B | 5.28B | 3.50B | -588.00M | 13.17B |
Operating Cash Flow | 0.00 | 3.94B | 14.43B | 10.69B | 5.71B | 17.16B |
Investing Cash Flow | 0.00 | -18.02B | -449.00M | -7.65B | -7.71B | -6.08B |
Financing Cash Flow | 0.00 | 13.97B | -7.41B | -3.50B | -12.30B | -309.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | 25.58B | 11.69 | 12.67% | 4.14% | 8.63% | -3.75% | |
76 Outperform | €123.29B | 13.20 | 7.64% | 3.79% | 14.83% | 62.73% | |
75 Outperform | 227.68B | 15.29 | 6.73% | 2.13% | 5.78% | 40.57% | |
71 Outperform | 2.37B | 8.08 | 6.49% | 1.81% | 9.21% | 24.86% | |
70 Outperform | 40.90B | 22.84 | 12.86% | 0.26% | 18.32% | -18.02% | |
63 Neutral | 67.77B | 19.75 | 5.02% | 2.01% | 1.10% | -64.41% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |
In August 2025, Autobacs Seven Co. reported an increase in both same-store and total-store sales by 5.4% and 6.6% respectively, compared to the same month the previous year. The growth was driven by strategic sales promotions for tires and strong service demand, supported by an additional weekend and national holiday compared to last year. This performance indicates a positive impact on the company’s operations and market positioning, reflecting effective sales strategies and robust demand for automotive maintenance services.
The most recent analyst rating on (JP:9832) stock is a Buy with a Yen1645.00 price target. To see the full list of analyst forecasts on Autobacs Seven Co stock, see the JP:9832 Stock Forecast page.
In July 2025, Autobacs Seven Co. reported a year-over-year increase in same-store and total-store sales by 0.8% and 2.1%, respectively. This growth was driven by strong demand for car maintenance services and safety inspections, as well as stable sales of batteries. The company’s performance indicates a positive trend in customer engagement and market positioning within the automotive service sector.
Autobacs Seven Co., Ltd. reported significant growth in its financial performance for the three months ended June 30, 2025, with net sales increasing by 18.9% year-on-year to ¥64,223 million. The company also saw substantial rises in operating profit and profit attributable to owners of the parent, indicating a strong recovery from the previous year’s downturn. This positive financial outcome suggests an improved market position and potential benefits for stakeholders, as the company maintains its dividend forecast for the fiscal year ending March 2026.
Autobacs Seven Co., Ltd. reported a significant increase in its financial performance for the three months ended June 30, 2025, with net sales rising by 18.9% year-on-year to ¥64,223 million. The company’s operating profit surged by 154.1%, and profit attributable to owners of the parent increased by 173.9%, reflecting a strong recovery from the previous year’s downturn. This robust performance underscores Autobacs’ improved market positioning and operational efficiency, potentially benefiting stakeholders through enhanced profitability and stability.
Autobacs Seven Co., Ltd. has completed the payment procedures for the disposal of 42,500 treasury shares as restricted stock remuneration, following a resolution made at the Board of Directors’ meeting on June 30, 2025. This move is part of the company’s strategy to allocate shares to its directors, excluding outside directors and those on the audit and supervisory committee, potentially impacting its operational dynamics and shareholder structure.
Autobacs Seven Co., Ltd. announced the disposal of 42,500 treasury shares as part of its Restricted Stock Remuneration Plan, aimed at enhancing value sharing with shareholders. This move is intended to motivate directors by aligning their interests with the company’s long-term value, as shares will be held until retirement, fostering sustained corporate value enhancement.